Merck has just registered the 15th…
Merck has just registered the 15th global phase 3 trial [...]
As scientific disinformation…
As scientific disinformation skyrockets, the Biotechnology Innovation Organization (BIO)—the world’s [...]
Though spending on pharmaceutical…
Though spending on pharmaceutical TV ads picked up last month [...]
Early Monday, Roche announced that…
Early Monday, Roche announced that the FDA cleared its 12-year-old [...]
The company believes the data for…
The company believes the data for zanzalintinib validate its hopes [...]
Novartis has shared detailed data…
Novartis has shared detailed data showing its radioligand therapy Pluvicto [...]
After upstaging Keytruda as…
After upstaging Keytruda as monotherapy for the treatment of first-line [...]
Europe’s leading cancer…
Europe’s leading cancer conference may be swimming in ADC data, [...]
Tubulis’ next-generation ADC has…
Tubulis’ next-generation ADC has been tied to an overall response [...]
GSK may be happy with the latest…
GSK may be happy with the latest readouts from two [...]